RNA Manufacturing Resources
-
Co-Precipitation Of Metal Carbonate Templated Protein Microparticles
12/9/2024
Explore the automated production of protein microparticles using an innovative method that offers a standardized and scalable solution for co-precipitation in biopolymer particle fabrication.
-
Outsourcing RNA-LNP Production: A Key To Competitive Success
3/6/2025
Manufacturing RNA-containing LNPs demands specialized expertise. Explore some of the challenges of RNA-LNP drug manufacturing and the advantages of outsourcing RNA-LNP formulations.
-
Manufacturing Challenges With High Concentration Biologics
3/18/2024
Explore key process operations, some of the challenges in manufacturing high-concentration biologics, and factors to consider for process optimization.
-
The Paradigm Shift: From Scale-Up To Scale-Out In Genetic Medicine
2/18/2025
The shift from "scale-up" to "scale-out" in genetic medicine enhances production speed, revolutionizing pharmaceutical manufacturing and accelerating life-saving therapies for global patient populations.
-
Charged For Action: The Hidden Secrets Of AEX Oligonucleotide Analysis
12/15/2025
Understanding how to fine-tune pH and ionic strength allows for the detection of truncated sequences and single-nucleotide variants, turning complex purification challenges into reproducible data.
-
The Secret To Pure Oligos: Why Anion Exchange Chromatography Rules At Scale
12/16/2025
Discover how anion exchange chromatography delivers high loading capacity and clinical-grade purity while addressing common scale-up challenges like aggregation and equipment longevity.
-
A Novel RNA Lipid Nanoparticle Platform: Gene-Edited CAR T Cells For Off-The-Shelf Cancer Therapy
4/14/2022
We report on the use of a novel lipid nanoparticle (LNP) reagent in a validated protocol to achieve successful complex gene editing in primary T cells with high efficiency while maintaining high cell viability.
-
Novel Lipid Nanoparticle Delivery Reagent And Manufacturing Workflow
4/18/2022
We aim to highlight that commercially available LNP reagent mix, GenVoy-ILM, is an accessible and easy-to-use LNP formulation that allows for rapid preclinical development of RNA vaccines.
-
Discussing mRNA: Challenges And Opportunities For Scale-Out And Optimization
2/6/2024
In a recent Cell & Gene Live event, experts explored challenges surrounding raw materials – both quality and supply – as well as the importance of achieving more efficient scale-out and turnaround times for mRNA production.
-
Single-Step Purification Of A 21-mer Oligonucleotide Using Capto™ Q ImpRes Resin
1/13/2025
Explore how the oligonucleotide therapeutics market is advancing with scalable solutions for high-purity purification, supporting global production of life-changing RNA therapies.